Leukemia & Lymphoma, Volume 61, Issue 7 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 7 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Rituximab biosimilars in clinical practice
Wojciech Jurczak & Monika Długosz-Danecka
Pages: 1523-1524
Published online: 06 Jul 2020
CitationforRituximab biosimilars in clinical practice | Full Text | References | PDF (246.2 KB) | EPUB
  • 138 Views
  • 1 CrossRef citations
  • 0Altmetric
The evolving definition of bulky disease for lymphoma
James P. Buteau, John F. Seymour & Michael S. Hofman
Pages: 1525-1528
Published online: 20 Jul 2020
First Page PreviewforThe evolving definition of bulky disease for lymphoma | Full Text | References | PDF (810.3 KB) | EPUB
  • 375 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?
Jingmei Hsu, Koen Van Besien & Frédéric Baron
Pages: 1529-1534
Published online: 30 May 2020
First Page PreviewforBusulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation? | Full Text | References | PDF (492 KB) | EPUB
  • 335 Views
  • 1 CrossRef citations
  • 0Altmetric

Reviews

Review
Thrombocytopenia in patients with myelofibrosis: management options in the era of JAK inhibitor therapy
Giulia Benevolo, Elena M. Elli, Paola Guglielmelli, Alessandra Ricco & Margherita Maffioli
Pages: 1535-1547
Published online: 24 Feb 2020
AbstractforThrombocytopenia in patients with myelofibrosis: management options in the era of JAK inhibitor therapy | Full Text | References | PDF (1.3 MB) | EPUB
  • 677 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Relapse or refractory Hodgkin lymphoma: determining risk of relapse or progression after autologous stem-cell transplantation
Gonzalo Bentolila & Astrid Pavlovsky
Pages: 1548-1554
Published online: 09 Mar 2020
AbstractforRelapse or refractory Hodgkin lymphoma: determining risk of relapse or progression after autologous stem-cell transplantation | Full Text | References | PDF (564.7 KB) | EPUB
  • 335 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles

Article
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma
Pamela B. Allen, Amy Ayers, Madhusmita Behera, Andrew M. Evens & Christopher Flowers
Pages: 1555-1564
Published online: 26 Feb 2020
AbstractforA systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma | Full Text | References | PDF (937.3 KB) | EPUB
  • 438 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients
Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, David F. Moreno, Gonzalo Gutiérrez-García, María Suárez-Lledó, Montserrat Rovira, Carmen Martínez, Laura Rosiñol, Ana Sofía Almeida Jorge, Alexandra Pedraza, Celia Cardozo, Pedro Puerta-Alcalde, Carolina Garcia-Vidal, Pedro Marín, Joan Cid, Miquel Lozano, Cristina Gallego, Adelina Hernando, Susana Segura, Álvaro Urbano-Ispizua & Francesc Fernández-Avilés
Pages: 1565-1574
Published online: 25 Mar 2020
AbstractforImpact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 295 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
The clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience
Kyoungmin Lee, Joo Young Ha, Ah Ra Jung, Yoon Sei Lee, Sang-wook Lee, Jin-Sook Ryu, Eun Jin Chae, Kyung Won Kim, Jooryung Huh, Chan-Sik Park, Dok Hyun Yoon & Cheolwon Suh
Pages: 1575-1583
Published online: 15 Apr 2020
AbstractforThe clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience | Full Text | References | PDF (958.5 KB) | EPUB | Supplemental
  • 760 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT
Gauthier Delaby, Marc-Antoine Hubaut, Franck Morschhauser, Alix Besson, Damien Huglo, Charles Herbaux & Clio Baillet
Pages: 1584-1591
Published online: 26 Feb 2020
AbstractforPrognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT | Full Text | References | PDF (1 MB) | EPUB
  • 217 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis
Rachel J. Bubik, Dylan M. Barth, Christopher Hook, Robert C. Wolf, Jessica M. Muth, Kristin Mara, Mrinal S. Patnaik, Rajiv K. Pruthi, Ariela L. Marshall, Mark R. Litzow, Michelle A. Elliott, William J. Hogan, Mithun V. Shah, Kebede H. Begna, Hassan Alkhateeb, Animesh Pardanani, Aneel A. Ashrani, Timothy G. Call, Candido E. Rivera, John K. Camoriano, Ronald S. Go, Alexandra P. Wolanskyj-Spinner & Sameer A. Parikh
Pages: 1592-1600
Published online: 11 Mar 2020
AbstractforClinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis | Full Text | References | PDF (1.3 MB) | EPUB
  • 539 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy
Joseph Tkacz, Jacob Garcia, Mathew Gitlin, Donna McMorrow, Sophie Snyder, Machaon Bonafede, Karen C. Chung & Richard T. Maziarz
Pages: 1601-1609
Published online: 09 Apr 2020
AbstractforThe economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 679 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis
Parvez Memet Shaikh, Fiori Alite, Novella Pugliese, Marco Picardi & John A. Vargo
Pages: 1610-1617
Published online: 12 Feb 2020
AbstractforConsolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 229 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Prognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma
Hánah N. Rier, Hardjit Kharagjitsing, Joost van Rosmalen, JLA van Vugt, Peter E. Westerweel, Eva de Jongh, Mark Kock & Mark-David Levin
Pages: 1618-1626
Published online: 13 Mar 2020
AbstractforPrognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma | Full Text | References | PDF (1 MB) | EPUB
  • 1664 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Article
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment
AnnaLynn M. Williams, Edwin van Wijngaarden, Christopher L. Seplaki, Charles E. Heckler, Miriam T. Weber, Paul M. Barr, Clive S. Zent & Michelle C. Janelsins
Pages: 1627-1635
Published online: 09 Mar 2020
AbstractforCognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment | Full Text | References | PDF (816.4 KB) | EPUB | Supplemental
  • 307 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)
Philip J. Meacham, AnnaLynn M. Williams, Myla Strawderman, Andrea M. Baran, William J. Archibald, Danielle S. Wallace, Nicholas P. Tschernia, Walter Richard Burack, Paul M. Barr & Clive S. Zent
Pages: 1636-1644
Published online: 16 Mar 2020
AbstractforAdditional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) | Full Text | References | PDF (935.6 KB) | EPUB
  • 273 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience
Asmaa M. Zahran, Sawsan M. Moeen, Ahmad F. Thabet, Amal Rayan, Mona Hussein Abdel-Rahim, Wael M. Y. Mohamed & Helal F. Hetta
Pages: 1645-1652
Published online: 20 Feb 2020
AbstractforMonocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience | Full Text | References | PDF (1.4 MB) | EPUB
  • 197 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia
Sarit Assouline, Lilian Amrein, Raquel Aloyz, Versha Banerji, Stephen Caplan, Carolyn Owen, Wanda Hasegawa, Sue Robinson, Sudeep Shivakumar, Anca Prica, Anthea Peters, Linda Hagerman, Laura Rodriguez, Tanya Skamene, Lawrence Panasci, Bingshu E. Chen & Annette E. Hay
Pages: 1653-1659
Published online: 10 Mar 2020
AbstractforIND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia | Full Text | References | PDF (859.7 KB) | EPUB | Supplemental
  • 289 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
An AKR1C3-specific prodrug with potent anti-tumor activities against T-ALL
Yanlan Wang, Yue Liu, Changhua Zhou, Chunnian Wang, Ning Zhang, Donglin Cao, Qing Li & Zhong Wang
Pages: 1660-1668
Published online: 24 Feb 2020
AbstractforAn AKR1C3-specific prodrug with potent anti-tumor activities against T-ALL | Full Text | References | PDF (1.1 MB) | EPUB
  • 337 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study
Michael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, Tim Synold, Xiwei Wu, Shu Tao, Samantha N. Hammond, Ralf Buettner, Lupe Duarte, Myo Htut, Chatchada Karanes, Nitya Nathwani, Flavia Pichiorri, Firoozeh Sahebi, James F. Sanchez, Arnab Chowdhury, Amrita Krishnan, Stephen J. Forman & Steven T. Rosen
Pages: 1669-1677
Published online: 08 Apr 2020
AbstractforRepurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study | Full Text | References | PDF (976.1 KB) | EPUB | Supplemental
  • 447 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia
Elizabeth DiMaggio, Jun-Min Zhou, Ryan Caddell, Rebecca Tombleson, Janelle Perkins, Claudio Anasetti, Farhad Khimani, Joseph Pidala, Taiga Nishihori, Lia Perez, Brian Betts, Hugo F. Fernandez & Asmita Mishra
Pages: 1678-1687
Published online: 05 Mar 2020
AbstractforReduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 401 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study
Kensuke Takaoka, Junji Koya, Akihide Yoshimi, Takashi Toya, Takashi Kobayashi, Yasuhito Nannya, Kumi Nakazaki, Shunya Arai, Hironori Ueno, Kensuke Usuki, Takeshi Yamashita, Daisuke Imanishi, Shinya Sato, Kenshi Suzuki, Hironori Harada, Atsushi Manabe, Yasuhide Hayashi, Yasushi Miyazaki & Mineo Kurokawa
Pages: 1688-1694
Published online: 11 Mar 2020
AbstractforNationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study | Full Text | References | PDF (817.1 KB) | EPUB | Supplemental
  • 284 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients
Fabio Guolo, Paola Minetto, Marino Clavio, Riccardo Marcolin, Maurizio Miglino, Monica Passannante, Fabrizio Caviglia, Filippo Ballerini, Elisabetta Tedone, Annalisa Kunkl, Rosa Mangerini, Paola Contini, Nicoletta Colombo, Antonia Cagnetta, Michele Cea, Enrico Carminati, Girolamo Pugliese, Marco Gobbi & Roberto Massimo Lemoli
Pages: 1695-1701
Published online: 18 Mar 2020
AbstractforPrognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients | Full Text | References | PDF (822.4 KB) | EPUB
  • 335 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia
Prajwal Dhakal, Elizabeth Lyden, Kate-Lynn E. Muir, Zaid S. Al-Kadhimi, Thuy Koll, Lori J. Maness, Krishna Gundabolu & Vijaya Raj Bhatt
Pages: 1702-1708
Published online: 11 Mar 2020
AbstractforPrevalence and effects of polypharmacy on overall survival in acute myeloid leukemia | Full Text | References | PDF (881.6 KB) | EPUB
  • 267 Views
  • 7 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement
Maria Pilar Gallego Hernanz, Nathalie Sorel, Sabrina Bouyer, Deborah Desmier, Mélanie Chollet, Natacha Maillard, Françoise Brizard, Niels Moya, Jose Miguel Torregrosa Diaz, Xavier Leleu & Jean-Claude Chomel
Pages: 1709-1713
Published online: 20 Feb 2020
First Page PreviewforLongitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement | Full Text | References | PDF (967.1 KB) | EPUB | Supplemental
  • 147 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid
Bibi Fatima Syed Shah Scharff, Signe Modvig, Maria Thastrup, Mette Levinsen, Matilda Degn, Lars Peter Ryder, Kjeld Schmiegelow, Claus Christensen & Hanne Vibeke Marquart
Pages: 1714-1718
Published online: 28 Feb 2020
First Page PreviewforA comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 237 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)
Ali G. Turhan, Patricia Hugues, Nathalie Sorel, Christophe Desterke, Jean-Henri Bourhis, Annelise Bennaceur-Griscelli & Jean-Claude Chomel
Pages: 1719-1723
Published online: 03 Mar 2020
First Page PreviewforEvidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML) | Full Text | References | PDF (782.9 KB) | EPUB
  • 139 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Spontaneous remission and clonal evolution in lenalidomide associated secondary AML
Daniel D. Waller, Yury Monczak, René P. Michel, Chaim Shustik & Michael Sebag
Pages: 1724-1727
Published online: 20 Feb 2020
First Page PreviewforSpontaneous remission and clonal evolution in lenalidomide associated secondary AML | Full Text | References | PDF (740.9 KB) | EPUB | Supplemental
  • 145 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Randomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Raffaele Palmieri, Sarah A. Buckley, Megan Othus, Anna B. Halpern, Mary-Elizabeth M. Percival, Bart L. Scott, Paul C. Hendrie, Pamela S. Becker, Vivian G. Oehler, Elihu H. Estey & Roland B. Walter
Pages: 1728-1731
Published online: 20 Feb 2020
First Page PreviewforRandomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm | Full Text | References | PDF (373.2 KB) | EPUB
  • 295 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma
Jeries Kort, Amanda Chidiac, Rola El Sayed, Radwan Massoud, Rita Nehme, Ali Bazarbachi & Jean El-Cheikh
Pages: 1732-1735
Published online: 22 Feb 2020
AbstractforSafety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma | Full Text | References | PDF (643.7 KB) | EPUB
  • 411 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ
Akihito Nagata, Noriko Doki, Hironori Harada, Toshiaki Takezaki, Tatsuya Konishi, Yuta Yamada, Satoshi Kaito, Shuhei Kurosawa, Kota Yoshifuji, Kaito Harada, Masahiro Sakaguchi, Shunichiro Yasuda, Kosuke Yoshioka, Kyoko Watakabe-Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Hideharu Muto, Takeshi Kobayashi, Kazuhiko Kakihana, Yuka Harada, Hisashi Sakamaki & Kazuteru Ohashi
Pages: 1736-1739
Published online: 26 Feb 2020
First Page PreviewforLate appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ | Full Text | References | PDF (704.3 KB) | EPUB
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Mobilization kinetics of peripheral blood stem cells with rescue plerixafor – real-world experience from a single center
Khaing-Shwe Wah Pwint, Yunxin Chen, Colin Phipps Diong, Yeow-Tee Goh, Dixon Grant, Aloysius Ho, William Hwang, Sathish Kumar, Yuh-Shan Lee, Francesca Lim, Yvonne Loh, Chandramouli Nagarajan, Jeffrey Quek, Miriam Tao, Hein Than & Yeh-Ching Linn
Pages: 1740-1743
Published online: 24 Feb 2020
First Page PreviewforMobilization kinetics of peripheral blood stem cells with rescue plerixafor – real-world experience from a single center | Full Text | References | PDF (604.2 KB) | EPUB
  • 124 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera
Ivan Krečak, Marko Lucijanić, Velka Gverić-Krečak & Nadira Duraković
Pages: 1744-1747
Published online: 25 Feb 2020
First Page PreviewforHyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera | Full Text | References | PDF (696.7 KB) | EPUB
  • 179 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial
Sebastian Grosicki, Ewa Lech-Maranda, Kanakasetty Govind Babu, Justyna Rybka, Elena Litvinskaya, Javier Loscertales, Iryna Kriachok, Janusz Kłoczko, Grygoriy Rekhtman, Wojciech Homenda, Jerzy Blonski, Tommaso Stefanelli, Ghislaine Vincent, Hiya Banerjee & Tadeusz Robak
Pages: 1748-1751
Published online: 28 Feb 2020
First Page PreviewforA 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial | Full Text | References | PDF (556.6 KB) | EPUB | Supplemental
  • 220 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement
Shweta Deshpande, Morie A. Gertz, Angela Dispenzieri, Shaji S. Kumar, Sameer A. Parikh & Eli Muchtar
Pages: 1752-1755
Published online: 11 Mar 2020
First Page PreviewforDaratumumab as successful initial therapy for AL amyloidosis with nerve involvement | Full Text | References | PDF (993.5 KB) | EPUB
  • 206 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count
Isolde Summerer, Claudia Haferlach, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach & Anna Stengel
Pages: 1756-1759
Published online: 19 Mar 2020
First Page PreviewforPrognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count | Full Text | References | PDF (706.3 KB) | EPUB | Supplemental
  • 747 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report
Rémy Nyga, Caroline Delette, Camille Mabille, Youssef Bennis, Taieb Chouaki, Mathieu Boone, Julien Maizel, Jean-Pierre Marolleau & Cédric Joseph
Pages: 1760-1762
Published online: 22 Feb 2020
First Page PreviewforIbrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report | Full Text | References | PDF (526.8 KB) | EPUB
  • 252 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Increased expression of miR-22 corresponds to the high-risk subtypes of myelodysplastic syndromes and lower OS rate
Yanna Ma, Tiankui Qiao & Yuesheng Meng
Pages: 1763-1765
Published online: 06 Mar 2020
First Page PreviewforIncreased expression of miR-22 corresponds to the high-risk subtypes of myelodysplastic syndromes and lower OS rate | Full Text | References | PDF (782.9 KB) | EPUB | Supplemental
  • 44 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Pembrolizumab immunotherapy for relapsed CNS Lymphoma
Jerome J. Graber, Benjamin Plato, Raya Mawad & Daniel J. Moore
Pages: 1766-1768
Published online: 23 Mar 2020
First Page PreviewforPembrolizumab immunotherapy for relapsed CNS Lymphoma | Full Text | References | PDF (607.5 KB) | EPUB
  • 559 Views
  • 14 CrossRef citations
  • 0Altmetric
Letter
Mantle cell lymphoma turned SOX11 negative after ibrutinib: a report of two cases
Toshiki Terao, Kentaro Narita, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi & Kosei Matsue
Pages: 1769-1771
Published online: 23 Apr 2020
First Page PreviewforMantle cell lymphoma turned SOX11 negative after ibrutinib: a report of two cases | Full Text | References | PDF (865.4 KB) | EPUB
  • 224 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype
Benoît Ducourneau, Laurène Fenwarth, Nicolas Duployez, Juliette Lambert, Stéphanie Struski, Isabelle Luquet, Agnès Daudignon, Nathalie Helevaut, Philippe Ruminy, Claude Preudhomme & Christine Terre
Pages: 1772-1774
Published online: 29 Mar 2020
First Page PreviewforCytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype | Full Text | References | PDF (939.1 KB) | EPUB | Supplemental
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric

Retraction

Retraction
Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia
Page: 1775
Published online: 14 Jul 2020
CitationforDetection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia | Full Text | PDF (93.4 KB) | EPUB
  • 648 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles